Related Experiment Video

Updated: May 26, 2026

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis

Ellen V Stevens1, Natalie Banet, Cercina Onesto

  • 1Department of Pharmacology; University of North Carolina at Chapel Hill; Chapel Hill, NC.

Small Gtpases
|December 7, 2011
PubMed

Insights

Rho GDP dissociation inhibitor 2 (RhoGDI2) unexpectedly promotes ovarian cancer invasion and metastasis. Suppressing RhoGDI2 increased tumor growth and spread, suggesting a novel therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Rho GDP dissociation inhibitor 2 (RhoGDI2) has known roles in various cancers.
  • Its expression and function in ovarian cancer remain largely unexplored.
  • Ovarian cancer is a significant global health concern with unmet therapeutic needs.

Purpose of the Study:

  • To investigate RhoGDI2 protein expression and its functional role in ovarian cancer.
  • To determine the correlation between RhoGDI2 expression and clinicopathological features of ovarian cancer.
  • To elucidate the molecular mechanisms underlying RhoGDI2's function in ovarian cancer cell invasion and metastasis.

Main Methods:

  • Protein gel blot analysis of RhoGDI2 in ovarian cancer cell lines.
  • Immunohistochemistry to assess RhoGDI2 expression in patient samples.
  • In vitro and in vivo assays to evaluate the functional impact of RhoGDI2 suppression on cancer cell growth and metastasis.
  • Co-immunoprecipitation to identify RhoGDI2 interacting partners and assessment of downstream signaling pathways.

Main Results:

  • RhoGDI2 expression varied in ovarian carcinoma cell lines, with higher levels in Ras-transformed cells.
  • RhoGDI2 was significantly overexpressed in high-grade ovarian cancers and correlated with histological subtype.
  • Suppression of RhoGDI2 enhanced anchorage-independent growth, invasion, and metastasis in vivo.
  • RhoGDI2 preferentially associated with Rac1, and its suppression decreased Rac1 activity and downstream signaling.

Conclusions:

  • RhoGDI2 antagonizes the invasive and metastatic potential of ovarian cancer cells.
  • RhoGDI2's function in cancer exhibits significant cell context-dependent differences.
  • RhoGDI2 represents a potential therapeutic target for inhibiting ovarian cancer progression.

More Related Videos

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...